Rephonic
Artwork for Vanguards of Healthcare by Bloomberg Intelligence

Vanguards of Healthcare by Bloomberg Intelligence

Bloomberg
Artificial Intelligence
Clinical Trials
Biotech
AI In Healthcare
HIV
FDA
Biotechnology
Venture Capital
Oncology
Home Care
Type 2 Diabetes
Medicaid
Health Systems
Prep
AI Technology
Cancer Treatment
Insulin Delivery Systems
FDA Approval
Long-Acting Treatments
Healthcare Revenue Cycle

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

PublishesTwice weeklyEpisodes153Founded3 years ago
Number of ListenersCategories
BusinessHealth & FitnessInvesting

Listen to this Podcast

Artwork for Vanguards of Healthcare by Bloomberg Intelligence

Latest Episodes

“You show me the incentive and I’ll show you the behavior,” says Sach Jain, founder and CEO of Carrum Health. Jain joins Bloomberg Intelligence analyst Jonathan Palmer to explain why misaligned incentives sit at the heart of specialty care’s cost pro... more

“It’s not just gonna be about image quality. It’s gonna be about image quality and interpretation”, Butterfly Network’s CEO Joe DeVivo explains to Bloomberg Intelligence. In this Vanguards of Healthcare podcast episode, DeVivo sits down with BI analy... more

“The number one thing that results in a better outcome for someone who is sick is actually, ‘Do you have an advocate on your side?’” says Farid Vij, co-founder and CEO of Citizen Health. Vij joins Bloomberg Intelligence analyst Jonathan Palmer to exp... more

“It’s designed to be simple in a way, even though it’s an incredibly complex device”, Distalmotion CEO Greg Roche explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Roche sits down with BI analyst Matt Henriksson fo... more

“Neuroscience is what oncology was 20 years ago,” says Cristian Massacesi, Chief Medical Officer and Head of Development at Bristol Myers Squibb. Massacesi joins Bloomberg Intelligence pharmaceuticals analyst Sam Fazeli to discuss Bristol Myers’ push... more

“If you plan, the cases can go much more smoothly. And if you have patient-specific instrumentation, they can go much more quickly” says restor3D’s CEO Kurt Jacobus in this episode of Vanguards of Healthcare. He sat down with BI analyst Matt Henrikss... more

“I think it’s the most exciting period in cancer discovery and development that I’ve experienced over the last 25 years,” says Susan Galbraith, executive vice president of oncology R&D at AstraZeneca. Galbraith joins Bloomberg Intelligence analyst Sa... more

“Forty percent of patients in this country alone in the first year drop out [of current retinal disease treatments] and every one of those patients ends up going blind. By far the most expensive disease in the world is blindness and the reason for th... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Invest Like the Best with Patrick O'Shaughnessy
Invest Like the Best with Patrick O'ShaughnessyColossus | Investing & Business Podcasts
Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Joe DeVivo
CEO of Butterfly Network, a medical device company
Butterfly Network
Episode: Butterfly Leads the Drive on Semiconductor to Make the Most Out of Ultrasound
Greg Roche
CEO, Distalmotion
Distalmotion
Episode: Distalmotion’s Approach to Spread Surgical Robots to More
Cristian Massacesi
Chief Medical Officer and Head of Development, Bristol Myers Squibb
Bristol Myers Squibb
Episode: Bristol Myers on Why Neuroscience Could Be the Next Oncology
Kurt Jacobus
CEO of Restore3D, a privately held medical device company
Restore3D
Episode: Restor3D Combines AI with 3D Printing to Create Personalized Ortho Solutions
Pravin Dugel
CEO of Ocular Therapeutix
Ocular Therapeutix
Episode: Ocular Therapeutix Cuts Blindness Toll
Paul LaViolette
CEO, Pulse Biosciences
Pulse Biosciences
Episode: Pulse Biosciences Brings Differentiated Nanosecond Technology to PFA
Rod Wong
Founder of RTW, a health care investor
RTW
Episode: RTW’s Rod Wong on Biotech’s Revival and the Global Shift
Neil Hattangadi
CEO and co-founder of Cortica
Cortica
Episode: Cortica’s Plan to Bring Value-Based Care to Autism
Chris Garabedian
CEO of Sarepta Therapeutics (history discussed) and founder of Xontogeny; investor with Perceptive Xontogeny Ventures
Xontogeny; Perceptive Xontogeny Ventures
Episode: Xontogeny's Case for Drug Developers Over Storytellers

Hosts

Matt Henriksson
Host of Vanguards of Health Care interview segments; Medical Technology Analyst
Sam Fazeli
Host of Vanguards of Health Care; Bloomberg Intelligence analyst focused on healthcare sector
Jonathan Palmer
Host of the Bloomberg Intelligence Vanguards of Health Care podcast; health care analyst

Top Investing Podcasts

The Ramsey Show
The Ramsey ShowRamsey Network
Prof G Markets
Prof G MarketsVox Media Podcast Network
Financial Audit
Financial AuditCaleb Hammer
Wake Up to Wealth
Wake Up to WealthBrandon Brittingham
NerdWallet's Smart Money Podcast
NerdWallet's Smart Money PodcastNerdWallet Personal Finance
The MORE Show
The MORE ShowJustin Colby, Bleav, Justin Colby
Money Guy Show
Money Guy ShowBrian Preston and Bo Hanson

Talking Points

Recent interactions between the hosts and their guests.

Butterfly Leads the Drive on Semiconductor to Make the Most Out of Ultrasound
Q: What role does Midjourney play in Butterfly's strategic vision and what could the partnership look like?
Midjourney contributes AI-driven imaging insights from ultrasound data; the collaboration explores licensing, discovery, and potential exclusivity in specific use cases, with a multi-year deal illustrating a broader platform strategy where AI is embedded on devices.
Butterfly Leads the Drive on Semiconductor to Make the Most Out of Ultrasound
Q: How does Butterfly plan to scale adoption beyond individual clinicians to hospitals and institutions?
Butterfly is building two paths: a consumer/clinic channel where thousands of doctors buy probes online for personal use and travel, and an institutional path with a SAS ecosystem (Compass AI) that aggregates data into hospital systems, enabling data capture, interoperability, and AI-driven workflows.
Butterfly Leads the Drive on Semiconductor to Make the Most Out of Ultrasound
Q: What makes the IQ3 different from prior generations, and how has it changed imaging quality?
IQ3 doubles processing power relative to the prior generation (IQ2), allowing higher image quality and better clinical decision support, while enabling longer battery life and more efficient processing; the ongoing roadmap suggests future generations will push image quality even further and enable on-device AI processing.
Bristol Myers on Why Neuroscience Could Be the Next Oncology
Q: With programs like PD-L1/PD-1–VGF bispecifics, what gives you confidence this could translate into an OS benefit, and how do you manage safety with such powerful combinations?
The mechanism shows higher response rates and progression-free survival, and early data suggest potential OS benefit; safety is being carefully managed through strategic trial design, patient stratification, and combination regimens, with seven pivotal studies in pulmitamig today and many more ongoing.
Bristol Myers on Why Neuroscience Could Be the Next Oncology
Q: From a portfolio perspective, how do you balance internal development versus external partnerships and licensing to hit your 2030 goals?
We are rigorous about attrition and timelines, and we actively tap external innovation to complement our internal strengths in targeted protein degradation, cell therapy, and antibodies, ensuring broad portfolio breadth while maintaining execution discipline.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

Vanguards of Healthcare features in-depth conversations with leaders in health tech, biotech, medical devices, and health-care investing. Episodes commonly center on company strategies, R&D progress, regulatory pathways, reimbursement and market access, as well as the evolving business models shaping healthcare innovation. Guests range from CEOs and founders to senior investors and policy-minded executives, providing practical insights into what drives value, execution, and scalable growth across health care and life sciences. Noteworthy elements include rigorous industry analyses, data-driven perspectives, and candid takes on AI, digital health, and the commercialization path for breakthrough therapies and devices. This mix makes it partic... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Invest Like the Best with Patrick O'Shaughnessy
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. The Readout Loud
5. BioCentury This Week

How many episodes of this podcast are there?

this podcast launched 3 years ago and published 153 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Joe DeVivo
2. Greg Roche
3. Cristian Massacesi
4. Kurt Jacobus
5. Pravin Dugel
6. Paul LaViolette
7. Rod Wong
8. Neil Hattangadi

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days